The Tea in STEM
The good, the bad, the dirty of the Science, Technology, Engineering and Math world.
New Episodes Weekly!
The Tea in STEM
FDA Decentralized Guidance with Ted Barduson PART 2
•
Anna Fehr and Alexandria Clark
In Part 2 of our discussion on the FDA’s new guidance for clinical trials, we move from theory to practice. Ted B. from Medvector joins us again to dive into solutions for addressing potential challenges when implementing this new flexibility allowing healthcare providers (HCPs) to conduct visits with Principal Investigator (PI) oversight.
